Biography & Research:
Dr. Charles Oh joined Corium, LLC in 2020 with more than 15 years of experience in the pharmaceutical/biotech industry. He has an established track record of industry accomplishments for achieving regulatory approval of multiple drugs and medical devices in North America and Europe, executing medical affairs strategies in support of commercial products, and leading scientific evaluations of business development opportunities. His industry experience encompasses a wide range of therapeutic areas, including pain management, cardiology, and neurology.
As chief medical officer at Corium, Inc., Charles drives the execution of clinical development programs, leads medical affairs to support commercial products, and builds the company's product pipeline. Prior to joining Corium, Charles served as Senior Vice President, Clinical Development at Acorda Therapeutics. Prior to that, he held roles of increasing responsibility and leadership at Johnson & Johnson and Purdue Pharma. Dr. Oh received his medical degree from Washington University in St. Louis and subsequently trained in internal medicine and cardiology. He also received an M.B.A. from the University of North Carolina at Chapel Hill and a B.S. in Biology from the University of Miami (FL).